What is hematocrit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Hematocrit?

Hematocrit is the percentage of blood volume occupied by red blood cells, calculated from the mean corpuscular volume (MCV) multiplied by the red blood cell count. 1

Definition and Measurement

Hematocrit represents the proportion of whole blood that consists of red blood cells, expressed as a percentage. 1 It is a calculated value derived from automated analyzer measurements of red blood cell count and mean corpuscular volume (MCV), using the formula: MCV × erythrocyte count = Hct. 1

Normal Reference Ranges

Normal hematocrit values vary significantly by age and sex: 2

  • Adult males/post-menopausal females: 47 ± 6% 2
  • Menstruating females: 41 ± 5% 2
  • Children 12-18 years (male): 43 ± 6% 2
  • Children 6-12 years: 40 ± 5% 2
  • Children 2-6 years: 37 ± 3% 2
  • Newborns: 51 ± 9% 1

Clinical Significance

Oxygen Transport Function

Hematocrit determines the oxygen-carrying capacity of blood, though it simultaneously increases blood viscosity and flow resistance. 3 This creates a dual role where optimal tissue oxygenation requires balancing adequate red cell mass against increased viscosity. 3

Thrombotic Risk

Elevated hematocrit is an independent risk factor for thrombosis. 4 Men with hematocrit ≥46% have a 1.5-fold increased risk of venous thromboembolism and a 2.4-fold increased risk of unprovoked venous thromboembolism compared to those with lower values. 5

Diagnostic Thresholds

  • Absolute polycythemia is always present when hematocrit exceeds 60% in males or 55% in females. 4
  • Elevated values requiring evaluation: >52% in males, >49.5% in women. 6
  • Transfusion threshold in stable hospitalized patients: Hematocrit 20-24% (hemoglobin 7-8 g/dL). 3

Important Measurement Limitations

Why Hemoglobin is Preferred Over Hematocrit

Hemoglobin is a more accurate measure than hematocrit for clinical assessment because: 1

  • Storage instability: MCV (and thus calculated hematocrit) is stable at room temperature for only 8 hours and refrigerated for only 24 hours, whereas hemoglobin remains unchanged. 1 Prolonged storage can falsely increase hematocrit by 2-4%. 1

  • Hyperglycemia interference: In the presence of hyperglycemia, MCV is falsely elevated, resulting in falsely elevated calculated hematocrit, but hemoglobin is unaffected. 1

  • Greater measurement variability: The coefficient of variation for hematocrit measurements is 2-3 times higher than for hemoglobin across automated analyzers. 1

Natural Variation

Within-subject biological variation of hematocrit is approximately 3%, which combined with analytical variation can explain a relative change of approximately 12% between two successive measurements taken 1 day to 1-2 months apart in healthy adults. 7 Seasonal variation can cause population mean hematocrit values to be approximately 3% lower in summer than winter, with some studies showing differences up to 7%. 7

Clinical Applications

Anemia Management

In chronic kidney disease, target hematocrit is 33-36% (corresponding to hemoglobin 11-12 g/dL), with survival rates improving when hematocrit exceeds 32-33%. 2

Cyanotic Heart Disease

In patients with cyanotic congenital heart disease, elevated hematocrit represents a physiological compensatory response to improve oxygen transport in the setting of chronic hypoxemia. 1 Routine phlebotomy is not supported by data and should be avoided, as there is no clear correlation between hematocrit level and hyperviscosity symptoms. 1

Fetal Medicine

In fetal transfusion, target hematocrit is approximately 40-50%, with higher levels avoided due to increased blood viscosity and theoretical increased risk of complications. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hematocrit and Hemoglobin Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The optimum hematocrit.

Clinical hemorheology and microcirculation, 2016

Guideline

Assessment Protocol for Incidental Erythrocytosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Haematocrit: within-subject and seasonal variation.

Sports medicine (Auckland, N.Z.), 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.